Time (h)
FIo. l. Fibrinolysis by RAW264.10 cells. Varying numbers of washed cells were plated in duplicate cultures on msI-fibrin-coated Linbro wells (FBI6-24TC) in Dulbecco's minimum essential medium (MEM) containing 5% acid-treated, heat-inactivated fetal bovine serum (ATHIFBS) ( ) or 5% of plasminogen-depleted ATHIFBS (---). The total volume was 2 ml and 0.2-ml samples were removed as indicated (1). The following cell numbers were plated: 2 x 105 (O); 4 X 105 (I-'1); and 8 x 105 (ZX). Each well contained 10 ~g fibrin/cm 2, with a total radioactivity of 6 × 104 cpm.
Materials and Methods
Except when otherwise stated, all reagents and procedures were as previously described (1, 6 ). Phorbol myristate acetate and phorbol were obtained from Consolidated Midland Corporation, Brewster, N. Y.
RA W264.10 Cell
Line. This is a clone derived from RAW264, a BALB/c tumor induced by Abelson leukemia virus whose macrophage nature has previously been described (9) . All incubations were carried out at 37°C in a 5% CO2-95% air atmosphere.
Results
Plasminogen-Dependent Fibrinolysis by RA W264. I0. For monitoring the fibrinolytic activity of RAW264.10 cells, varying numbers of washed cells were plated directly onto t25I'-fibrin and the fibrinolytic activity measured by counting released radioactivity at various time points. As can be seen in Fig. 1 , after an initial short lag period, there is an approximately linear fibrinolytic activity detected in these cells which is predominantly plasminogen dependent.
Inhibition of the Secretion of Plasmmogen
Activator by Anti-Inflammatory Glucocorticoids. Serum-free medium was collected from the cultures of RAW264.10 cells and assayed for plasminogen activator. As can be seen from Table I , these cells, as has been shown for activated mouse macrophages, secrete plasminogen activator. Antiinflammatory glucocorticoids at low concentrations inhibit the synthesis and secretion of plasminogen activator from activated mouse macrophages (6) . In Table I , the effect of 10 -7 M dexamethasone on the extracellular and cell-associated enzyme levels in RAW264.10 cells is shown. As with peritoneal macrophages, this anti-inflammatory agent is able to decrease the enzyme levels without affecting the secretion of another enzyme, lysozyme (Table I) . Dexamethasonc was added at the start of the culture. After 24 h, the serum-free conditioned medium (CM) was collected, the cultures washed two times with phosphate-buffered saline (PBS), the cells lysed by the addition of Triton X-100 (Rohm & Haas Co., Philadelphia, Pa.) (0.2% vol/vol in water), and scraped from the surface of the dish with a plastic policeman. The conditioned media and the cells were then assayed for plasminogen activator and the conditioned media for lysozyme (I, 6). * No plasminogen-independent fibrinolysis could be detected when plasminogen was omitted fiom the assay mixture. * I U of plasminogen activator is defined as the amount that releases 10q, of the initial radioactivity in 4 h (I). A dose response for dexamethasone inhibition on the extracellular enzyme levels is depicted in Fig. 2 . The lysozyme secretion was not affected by these doses of dexamethasone (J. A. Hamilton, unpublished observations).
It has previously been shown that for the glucocorticoids, the anti-inflammatory drugs are the most effective at decreasing plasminogen-activator levels of mouse macrophages (6). The relative abilities of a series of glucocorticoids at 10 -7 M to suppress extracellular plasminogen-activator levels from the RAW264.10 cells are listed in Table II . The relative inhibitory potencies are similar for these neoplastic cells and for the peritoneal mouse macrophages (6).
Stimulation of the Secretion of Plasminogen ,Activator by Phorbol Myristate Acetate (PMA). PMA, a tumor promoter in a mouse skin carcinogenesis model (11), has been shown to induce and stimulate plasminogen-activator production from mouse peritoneal macrophages (7). The parent alcohol, phorbol, is inactive. In Fig. 3 , PMA is shown to increase plasminogen-activator secretion from RAW264.10 cells at low concentrations whereas phorbol itself is inactive. The cell-associated enzyme levels are increased at most two-to threefold (J. A. Hamilton, unpublished observations). 
Log Drug Concentration (M) Discussion The above study indicates that a mouse macrophage cell line (RAW264.10) can spontaneously synthesize and secrete the neutral protease, plasminogen activator. In addition, this line produces less enzyme in the presence of low concentrations of glucocorticoids but more enzyme when treated with the tumor promoter, PMA.
Certain irritants, such as thioglycollate medium and asbestos fibers, are able to elicit macrophages into the peritoneal cavity of mice which synthesize much higher levels of plasminogen activator than the resident, unstimulated macrophages (1, 2). The amount of enzyme produced by the RAW264.10 line is comparable to that produced by the so-called activated macrophages and it is possible that this line is expressing a permanent state of activation. Further experiments are needed to understand the significance of the enzyme synthesis for RAW264.10 metabolism.
We have shown here that low doses of dexamethasone can inhibit production of plasminogen activator by the RAW264.10 line and the spectrum of the abilities of other glucocorticoids to inhibit enzyme production is similar to that found for thioglycollate-induced mouse peritoneal macrophages (6) . Interestingly, the relative potencies of these drugs parallels their abilities to function as anti-inflammatory agents (12) . Also, as with thioglycollate-and asbestos-induced macrophages, lysozyme secretion is not inhibited. These observations suggest that the cell line can modulate its enzyme production in response to glucocorticoids in a similar manner to mouse peritoneal macrophages. Thus the cell line may provide a useful model system for studying glucocorticoid-receptor interaction and possibly for receptor isolation from the macrophage. These cells may also enable the details for the mechanism of the glucocorticoid control of enzyme synthesis to be elucidated.
The cocarcinogenic effects of PMA and other promoting substances are known to be inseparable from a powerful inflammatory response that is associated with the presence of lymphocytes and macrophages in the affected areas of skin (t3), and protease levels in the skin are shown to increase in conjunction with the inflammatory response. Furthermore, nanomolar concentrations of tumor-promoting phorbol esters (but not their inactive analogues) induce changes in cultured cells that resemble those seen on transformation with either chemical carcinogens or tumor viruses, and further enhance the expression of these transformation-specific phenotypic features in already transformed cells (14) . They also reversibly inhibit terminal differentiation in a number of different cell types (14) . We have shown here that the cell line RAW264.10 can increase plasminogen-activator production in response to low concentrations of PMA with a similar dose response to that found with mouse peritoneal macrophages and, as with the peritoneal macrophages, the parent alcohol is without effect (7). These observations suggest that the cell line possesses similar receptors or other cellular components to peritoneal macrophages which can respond to PMA and again points to the possible usefulness of this line in the study of macrophage physiology.
In summary, we suggest that the macrophage tumor cell line, RAW264.10, provides a cell type which should be useful in delineating how macrophages regulate the production of plasminogen activator. The cell line may be useful for the isolation of receptors for glucocorticoids and for studying molecular events associated with PMAcell interactions. Studies on the relationship between plasminogen activator synthesis and the other functional properties of RAW264.10 (9, 10) are currently in progress.
Summary
The macrophage cell line, RAW264.10, synthesizes and secretes plasminogen activator. Production of this enzyme is inhibited by low concentrations of glucocorticoids and increased by phorbol myristate acetate. It is proposed that this line could be a suitable model for the regulation of enzyme synthesis by mouse peritoneal macrophages.
